Chelsea Therapeutics (Weighted Average Cost of Capital (WACC) Analysis)
Improve your investment analysis with by seeing the Chelsea Therapeutics's Discounted Cash Flow analysis, Chelsea Therapeutics's Warren Buffet analysis, and Chelsea Therapeutics's Comparable Multiple analysis.
Helpful Information for Chelsea Therapeutics's Analysis
What is the WACC Formula? Analyst use the WACC Discount Rate (weighted average cost of capital) to determine Chelsea Therapeutics's investment risk. WACC Formula = Cost of Equity (CAPM) * Common Equity + (Cost of Debt) * Total Debt. The result of this calculation is an essential input for the discounted cash flow (DCF) analysis for Chelsea Therapeutics. Value Investing Importance? This method is widely used by investment professionals to determine the correct price for investments in Chelsea Therapeutics before they make value investing decisions. This WACC analysis is used in Chelsea Therapeutics's discounted cash flow (DCF) valuation and see how the WACC calculation affect's Chelsea Therapeutics's company valuation.
WACC Analysis Information
1. The WACC (discount rate) calculation for Chelsea Therapeutics uses comparable companies to produce a single WACC (discount rate). An industry average WACC (discount rate) is the most accurate for Chelsea Therapeutics over the long term. If there are any short-term differences between the industry WACC and Chelsea Therapeutics's WACC (discount rate), then Chelsea Therapeutics is more likely to revert to the industry WACC (discount rate) over the long term.
2. The WACC calculation uses the higher of Chelsea Therapeutics's WACC or the risk free rate, because no investment can have a cost of capital that is better than risk free. This situation may occur if the beta is negative and Chelsea Therapeutics uses a significant proportion of equity capital.